Results 131 to 140 of about 3,164,975 (245)
HTLV screening and confirmatory testing among blood donors in São Paulo: A cross‐sectional study
Transfusion Medicine, EarlyView.Abstract Introduction Human T‐cell lymphotropic virus types 1 and 2 (HTLV‐1/2) are transfusion‐transmissible retroviruses associated with severe diseases, and blood donor screening is mandatory in Brazil. Increasing HTLV‐related discard rates at our institution prompted this study to determine the prevalence and incidence of HTLV‐1/2 and to investigate
Suzete C. Ferreira +11 more
wiley +1 more source
Economic assessment of an anti-HCV screening program in Italy.
Value in Health, 2013 M. Ruggeri +3 more
semanticscholar +1 more source
Hepatitis E Infection in Patients With IBD Treated With Advanced Therapy: A Case Series
JCC Plus, Volume 1, Issue 5, September 2026.ABSTRACT Background and Aims Hepatitis E virus is an RNA virus with 8 genotypes. Infection is usually acute and asymptomatic, but chronic infection may develop in immunocompromised individuals. Data on the course of hepatitis E virus infection in patients with inflammatory bowel disease receiving advanced therapy are limited.
Jakub Jirsa +2 more
wiley +1 more source
Adenosine kinase is a key determinant for the anti‐HCV activity of ribavirin
Hepatology, 2013 Kyoko Mori +6 more
semanticscholar +1 more source
Muscle &Nerve, Volume 74, Issue 3, Page 605-615, September 2026.ABSTRACT Introduction/Aims Combined central and peripheral demyelination (CCPD) is a rare dysimmune disorder sharing features with multiple sclerosis (MS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Direct comparisons of central and peripheral diagnostic findings across these entities remain limited. We, therefore, performed a
N. Dubuisson +6 more
wiley +1 more source
Alimentary Pharmacology &Therapeutics, Volume 64, Issue 5, Page 625-634, September 2026.HBV reactivation incidence varied across immunosuppressive and chemotherapeutic agents. Clinically meaningful HBV reactivation was also observed in patients receiving corticosteroids and conventional immunosuppressive therapies. ABSTRACT Background Data on the incidence of hepatitis B virus reactivation (HBVr) remain limited. In Japan, patients who are
Kazuhiko Ikeuchi +8 more
wiley +1 more source
Immunology, Volume 179, Issue 1, Page 138-148, September 2026.This study investigates the impact of switching to long‐acting (LA) injectable cabotegravir and rilpivirine (CAB/RPV‐LA) on immune‐activation and ‐senescence in people with HIV (PWH). Thirty‐seven PWH switching to CAB/RPV‐LA and nine continuing oral ART were analysed over 72 weeks. LA therapy led to significant reductions in activation T and senescence
Mariasilvia Guardiani +16 more
wiley +1 more source
Characterising Hepatitis D Virus in the UK From 2011 to 2021
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT Little is known about hepatitis B virus (HBV) and Hepatitis D virus (HDV) coinfection in the UK. HDV screening is recommended among all individuals with HBV, with coinfection associated with increased disease progression. Using data on HDV testing, shared by 11 laboratories in the UK who reported undertaking HDV testing, and national testing ...
R. Simmons +67 more
wiley +1 more source